Aqueous root extract of Dicoma anomala Sond ameliorates isoproterenol–induced myocardial infarction in Wistar rats
Purpose: To evaluate the protective potentials of the aqueous root extract of Dicoma anomala (AQRED) against isoproterenol (ISP)-induced myocardial damage in Wistar rats.
Methods: Myocardial damage was induced in Wistar rats by isoproterenol (60 mg/kg body weight, b.w.) Various concentrations (125, 250, and 500 mg/kg b.w.) of AQRED and their effects on the rats’ feed and water intake, body weight changes, serum enzymes, including aspartate transaminase (AST), alanine transaminase (ALT) creatinine phosphokinase (CPK), as well as tissue antioxidant enzymes, including catalase (CAT), glutathione peroxidase (GP) and lipid peroxidation, during a 30-day experimental period were examined.
Results: ISP-treated rats showed no significant (p > 0.05) effect on the feed, water and body weight but increased significantly (p < 0.05) AST, ALT, CPK and lipid peroxidation while significantly reducing CAT and GP levels (p < 0.05). Treatment with different doses of AQRED significantly (p < 0.05) reversed the activity of these enzymes and cardiac lipid peroxidation towards control levels. Histopathological examination of ISP-induced myocardial rats treated with D. anomala revealed evidence of oedema and myocardial necrosis at 125 and 250 mg/kg b.w. doses, but these alterations were ameliorated or cleared at 500 mg/kg dose, suggesting attainment of maximum efficacy.
Conclusion: The findings indicate the ameliorative potential of AQRED in myocardiac disease, and therefore, could be of therapeutic significance in the management or treatment of cardiac-related diseases.
Keywords: Antioxidant enzymes, Dicoma anomala, Lipid peroxidation, Serum enzymes
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.